A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries

Journal of Medical Microbiology

Volumn 57, Issue 10, 2008, Pages 1213-1219

  Matsuoka, Masanori ^a   Aye, Khiri Saw ^b   Kyaw, Kyaw ^c   Tan, Esterlina Virtudes ^d   Balagon, Ma Victoria ^d   Saunderson, Paul ^d   Gelber, Robert ^d   Makino, Masanao ^e   Nakajima, Chie ^f   Suzuki, Yasuhiko ^f  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Department of Medical Research ^*  (Myanmar)

^c Yangon General Hospital   (Myanmar)

^d Leonard Wood Memorial Center for Leprosy Research Philippines   (Philippines)

^e National Leprosy Hospital Okukomyoen   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; OFLOXACIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIUM MUTANT; DEVELOPING COUNTRY; DNA MICROARRAY; FEASIBILITY STUDY; FOLP1 GENE; GENE MUTATION; GYRA GENE; LEPROSY; LEPROSY DRUG SUSCEPTIBILITY DNA MICROARRAY; MYCOBACTERIUM LEPRAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RPOB GENE; SEQUENCE ANALYSIS;

BACTERIAL PROTEINS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MUTATION; MYANMAR; MYCOBACTERIUM LEPRAE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHILIPPINES; PREVALENCE;

EID: 53749106935     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/002600-0     Document Type: Article

References (23)

1. Cambau, E., Perani, E., Guillemin, I., Jamet, P. & Ji, B. (1997). Multidrug rtesistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349, 103-104.
2. Cambau, E., Bonnafous, P., Perani, E., Sougakoff, W., Ji, B. & Jarlier, V. (2001). Molecular detection of rifampicin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy. Clin Infect Dis 34, 39-45.
3. Cambau, E., Carthagena, L., Chauffour, A., Ji, B. & Jarlier, V. (2006). Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Clin Infect Dis 42, 238-241.
4. de Wit, M. Y. L., Faber, W. R. S., Krieg, R., Douglas, J. T., Lucas, S. B., Montreewasuwat, N., Pattyn, S. R. N., Hussain, R., Ponnighaus, J. M. & other authors (1991). Application of polymerase chain reaction for the detection of Mycobacterium leprae in skin tissue. J Clin Microbiol 29, 906-910.
5. Honoré, N. & Cole, S. T. (1993). Molecular basis of rifampicin resistance in Mycobacterium leprae. Antimicrob Agents Chemother 37, 414-418.
6. Honoré, N., Perani, E., Telenti, A., Grosset, J. & Cole, S. T. (1993). A simple and rapid technique for the detection of rifampicin resistance in Mycobacterium leprae. Int J Lept Other Mycobact Dis 61, 600-604.
7. Ji, B. (2002). Rifampicin resistant leprosy: a review and research proposal of a pilot study. Lepr Rev 73, 2-8.
8. Kai, M., Matsuoka, M., Nakata, N., Maeda, S., Gidoh, M., Maeda, Y., Hashimoto, K., Kobayashi, K. & Kashiwabara, Y. (1999). Diaminodiphenilsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene. FEMS Microbiol Lett 177, 231-235.
9. Lee, S. B., Kim, S. K., Kang, T. J., Chae, G. T., Chun, J. H., Shin, H. K., Kim, J. P., Ko, Y. H. & Kim, N. H. (2001). The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycoabcterium leprae isolates from South Korea. Ann Trop Med Parasitol 95, 429-432.
10. Maeda, S., Matsuoka, M., Nakata, N., Kai, M., Maeda, Y., Hashimoto, K., Kimura, H., Kobayashi, K. & Kashiwabara, Y. (2001). Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45, 3635-3639.
11. Matsuoka, M., Kashiwabara, Y. & Namisato, Y. (2000). A Mycobacterium leprae isolate resistant to dapsone, rifampicin, ofloxacine and Sparfloxacin. Int J Lepr Other Mycobact Dis 68, 452-455.
12. Matsuoka, M., Kashiwabara, Y., Zhang, L., Gotoh, M. & Kitajima, S. (2003). A second case of multidrug resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy. Int J Lepr Other Mycobact Dis 71, 240-243.
13. Matsuoka, M., Zhang, L., Morris, M. F., Legua, P. & Wiens, C. (2005). Polymorphism in the rpoT gene in Mycobacterium leprae isolates obtained from Latin American countries and its possible correlation with the spread of leprosy. FEMS Microbiol Lett 243, 311-315.
14. Matsuoka, M., Teky, B., Khin, S. A., Kyaw, K., Tan, E. V., dela Cruz, E., Gelber, R., Saunderson, P., Balagon, M. A. & Pannikar, V. (2007). The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev 78, 343-352.
15. Rossau, R., Traore, H., de Beenhouwer, H., Mijs, W., Jannes, G., De Rijk, P. & Portaels, F. (1997). Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother 41, 2093-2098.
16. Sapkota, B. R., Ranjit, C., Neupane, K. D. & Macdonald, M. (2008). Developing and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae. J Med Microbiol 57, 179-184.
17. Shepard, C. (1960). The experimental disease that follows the injection of human leprosy bacillus into footpads of mice. J Exp Med 112, 445-454.
18. WHO (1998). WHO Expert Committee on Leprosy, seventh report. Technical report series 87. Geneva: World Health Organization.
19. Williams, D, L. & Gillis, T. P. (2004). Molecular detection of resistance in Mycobacterium leprae. Lepr Rev 75, 118-130.
20. Williams, D. L., Waguespack, C., Eisenack, K., Crawford, J. T., Portaels, F., Salfinger, M., Nolan, M. C., Abe, C., Stich-Groh, V. & Gillis, T. P. (1994). Characterization of rifampicin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 38, 2380-2386.
21. Williams, D. L., Spring, L., Harris, E., Roche, P. & Gillis, T. P. (2000). Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. Antimicrob Agents Chemother 44, 1530-1537.
22. Williams, D. L., Pittman, T. L., Gillis, T. P., Matsuoka, M. & Kashiwabara, Y. (2001). Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis. J Clin Microbiol 39, 2083-2088.
23. Zhang, L., Namisato, M. & Matsuoka, M. (2004). A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampicin. Int J Lepr Other Mycobact Dis 72, 468-472.